3rd Quarter - Report
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for BIOTECHNOLOGY INDUSTRY ORGANIZATION
Income
$10,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
340B Drug Discount Program - Program Implementation Oversight. Reimbursement for Innovative Products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH L. ROBERTS | — |
Medicare/Medicaid MMM
340B Drug Discount Program - Program Implementation Oversight. Reimbursement for Innovative Products. Medicare Part D - Benefit redesign legislation and patient access changes. Center for Medicare and Medicaid Innovation - Demonstration program design updates and Congressional oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH L. ROBERTS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.